Search
Home
Sitemap
Glossary
About us
Our Products
R & D
Your Health
Media Centre
Investor Relations
Careers
Contact Us
Transforming Allergy Treatment
Media Centre
All News for 2007
November 30.2007
Allergy Therapeutics plc AGM resolutions passed
Read More
November 01.2007
Update on FDA Clinical Hold
Read More
September 25.2007
Preliminary Results
Read More
July 24.2007
Clinical Development Update
Read More
July 11.2007
FDA Clinical Update
Read More
June 14.2007
Pollinex(R) Quattro Grass Phase III Study Fully Recruited
Read More
May 29.2007
Allergy Therapeutics - Eur40 million Debt Facility
Read More
May 29.2007
Euro40 million Debt Facility
Read More
May 11.2007
Approval of fundamental Vaccine technology Patent
Read More
May 10.2007
Allergy Therapeutics plc Preliminary Results Statement
Read More
April 18.2007
Announces Conclusive Results Of Oral Allergy Vaccine Study. Promising Preliminary Results Reinforced In High Allergen Dose Group
Read More
April 02.2007
Commencement of Dosing in Pollinex(R) Quattro Phase III Ragweed Trial. Now running the two largest international allergy vaccine trials ever conducted
Read More
January 31.2007
FDA agrees to single pivotal Phase III trial for registration
Read More
January 26.2007
Opening of Noon and Freeman Buildings. Significant manufacturing investment leading to creation of 80 jobs.
Read More
January 23.2007
Commencement of Pollinex(R) Quattro Grass Dosing. First ever global allergy vaccine trial.
Read More
Latest News
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
Press Articles
Company Literature
Image Library
Media Contacts